SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

January 30, 2024

https://www.globenewswire.com/news-release/2024/01/30/2820499/0/en/SCYNEXIS-to-Participate-in-Guggenheim-s-6th-Annual-Biotechnology-Conference.html

JERSEY CITY, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced David Angulo, M.D., President and Chief Executive Officer, will present at Guggenheim’s 6th Annual Biotechnology Conference on Wednesday, February 7 at 11:00 A.M. ET.

Read more at globenewswire.com

Related news for (SCYX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.